Letters to the Editor

Outcome of infants with acute lymphoblastic leukemia treated with the Chinese Children's Cancer Group Acute Lymphoblastic Leukemia 2015 study protocol

Department of Pediatrics, Hong Kong Children’s Hospital, The Chinese University of Hong Kong, Hong Kong SAR
Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children’s Medical Center, Shanghai
Department of Pediatrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, Chengdu
Department of Hematology/Oncology, Chongqing Medical University Affiliated Children's Hospital, Chongqing
Department of Hematology/Oncology, Children's Hospital of Nanjing Medical University, Nanjing
Department of Pediatrics, Affiliated Hospital of Qingdao University, Qingdao
Department of Hematology/Oncology, Shanghai Children's Hospital, Shanghai
Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou
Department of Pediatrics, Anhui Medical University Second Affiliated Hospital, Anhui
Department of Hematology/Oncology, Xi 'an Northwest Women's and Children's Hospital, Xi 'an
Department of Hematology/Oncology, KunMing Children’s Hospital, Kunming
Department of Pediatrics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin
Department of Pediatrics, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou
Department of Pediatrics, Qilu Hospital of Shandong University, Jinan
Department of Hematology/Oncology, Children's Hospital of Fudan University, Shanghai
Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou
Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Department of Hematology/Oncology, Jiangxi Provincial Children's Hospital, Nanchang
Department of Pediatrics, Xiangya Hospital Central South University, Changsha
Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children’s Medical Center, Shanghai
Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, and National Children’s Medical Center, Shanghai
Department of Pediatrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, Chengdu
Departments of Oncology, Pathology, and Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee
Department of Pediatrics, Hong Kong Children’s Hospital, The Chinese University of Hong Kong, Hong Kong SAR
Haematologica Early view Apr 18, 2024 https://doi.org/10.3324/haematol.2024.285201